1月28日(路透社)—— Aptevo Therapeutics Inc发布公告称,公司招股说明书涉及由售股股东发起的普通股发售计划,拟出售股份数量上限达7,075,471股。此次申报文件已正式提交备案。
更多公司相关资讯请参考代码:APVO.O
1月28日(路透社)—— Aptevo Therapeutics Inc发布公告称,公司招股说明书涉及由售股股东发起的普通股发售计划,拟出售股份数量上限达7,075,471股。此次申报文件已正式提交备案。
更多公司相关资讯请参考代码:APVO.O
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.